Biogen
BIIB
974 hedge funds and large institutions have $85.6B invested in Biogen in 2015 Q2 according to their latest regulatory filings, with 100 funds opening new positions, 367 increasing their positions, 348 reducing their positions, and 85 closing their positions.
18% more first-time investments, than exits
New positions opened: 100 | Existing positions closed: 85
5% more repeat investments, than reductions
Existing positions increased: 367 | Existing positions reduced: 348
1% more funds holding
Funds holding: 967 → 974 (+7)
5% less capital invested
Capital invested by funds: $90.2B → $85.6B (-$4.63B)
24% less funds holding in top 10
Funds holding in top 10: 68 → 52 (-16)
30% less call options, than puts
Call options by funds: $1.21B | Put options by funds: $1.72B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$549M |
| 2 |
JSP
Jackson Square Partners
Larkspur,
California
|
+$313M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
+$206M |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$189M |
| 5 |
VOYA Investment Management
Atlanta,
Georgia
|
+$184M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$358M |
| 2 |
D.E. Shaw & Co
New York
|
-$306M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$249M |
| 4 |
Winslow Capital Management
Minneapolis,
Minnesota
|
-$246M |
| 5 |
MCM
Marsico Capital Management
Denver,
Colorado
|
-$215M |
BIIB Hedge Fund Activity: Q2 2015 in Review
974 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Biogen (BIIB) for Q2 2015, worth a combined $85.6B — down 5.1% from $90.2B a quarter earlier.
Buyers outnumbered sellers: 100 funds opened new BIIB positions and 85 closed out — a net gain of 15 holders — while 367 added to existing stakes and 348 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $549M. The largest seller was JP Morgan Chase, cutting an estimated $358M.
- 974 institutional investors held Biogen (BIIB) as of Q2 2015, up from 967 in Q1 2015.
- Funds reported $85.6B of Biogen stock for Q2 2015, down 5.1% quarter-over-quarter.
- 100 funds opened new Biogen positions in Q2 2015 and 85 closed out, a net change of +15 holders.
- The largest Biogen buyer in Q2 2015 was Wellington Management Group, an estimated $549M added.
- The largest Biogen seller in Q2 2015 was JP Morgan Chase, an estimated $358M sold.
Based on aggregated 13F filings for Q2 2015.